EMY.HM
Embraer SA
HamburgEUREQUITY
DELAYED
Last price
65.40
▲ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
63.80
Prev close
65.40
Day high
0.00
Day low
0.00
Volume
0
Market cap
—
P/E (TTM)
—
52W range
0.00 – 67.80
Day trading desk
Gap from prior close
-2.45%
Prior close 65.40
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
2.51%
63.80 – 65.40
Position in range
100%
Near session high
ATR (14D)
1.61
2.47% of price
Prior day high
66.20
PDH
Prior day low
65.40
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 1
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.31%
+1.7%
1M
+14.74%
+11.0%
3M
+33.47%
+30.4%
6M
+6.51%
-4.6%
YTD
+20.66%
+8.4%
1Y
+34.29%
+14.3%
3Y
+377.37%
+303.2%
5Y
+391.73%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on EMY.HM open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $7.58B | $6.39B | $5.27B | $4.54B | +18.5% |
| Operating revenue | $7.58B | $6.39B | $5.27B | $4.54B | +18.5% |
| Cost of revenue | $6.25B | $5.24B | $4.36B | $3.63B | +19.2% |
| Gross profit | $1.33B | $1.15B | $909.60M | $912.20M | +15.2% |
| Research & development | $74.40M | $55.00M | $90.30M | $110.00M | +35.3% |
| Selling, general & admin | $552.10M | $508.60M | $519.60M | $459.30M | +8.6% |
| Total operating expense | $720.20M | $485.90M | $647.50M | $691.80M | +48.2% |
| Operating income | $608.50M | $667.20M | $262.10M | $220.40M | -8.8% |
| Net interest income | -$161.70M | -$108.30M | -$125.20M | -$192.40M | -49.3% |
| Pre-tax income | $267.60M | $557.00M | $120.70M | -$205.80M | -52.0% |
| Tax provision | -$91.40M | $202.40M | -$43.60M | -$2.30M | -145.2% |
| Net income | $351.90M | $352.50M | $164.00M | -$185.40M | -0.2% |
| Net income to common | $351.90M | $352.50M | $164.00M | -$185.40M | -0.2% |
| Basic EPS | 1.92 | 1.92 | 0.88 | -1.00 | 0.0% |
| Diluted EPS | 1.92 | 1.92 | 0.88 | -1.00 | 0.0% |
| EBIT | $464.60M | $769.50M | $356.50M | $18.10M | -39.6% |
| EBITDA | $724.10M | $1.01B | $598.20M | $228.40M | -28.5% |
| Basic shares | 183.10M | 183.65M | 183.66M | 183.66M | -0.3% |
| Diluted shares | 183.10M | 183.65M | 183.66M | 183.66M | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.95B | $1.56B | $1.63B | $1.82B | — | +24.7% |
| Cash & short-term investments | $2.63B | $2.20B | $2.15B | $2.31B | — | +19.2% |
| Accounts receivable | $289.40M | $320.80M | $217.60M | $202.90M | — | -9.8% |
| Inventory | $3.18B | $2.90B | $2.61B | $2.30B | — | +9.9% |
| Total current assets | $7.15B | $6.51B | $6.06B | $5.76B | — | +9.8% |
| Property, plant & equipment | $2.24B | $2.05B | $1.86B | $1.71B | — | +9.3% |
| Goodwill & intangibles | $2.72B | $2.50B | $2.33B | $2.25B | — | +8.7% |
| Total assets | $12.92B | $11.82B | $10.78B | $10.14B | — | +9.3% |
| Total current liabilities | $4.76B | $4.42B | $3.67B | $3.22B | — | +7.8% |
| Current debt | $105.30M | $113.80M | $127.10M | $308.50M | — | -7.5% |
| Long-term debt | $2.49B | $2.38B | $2.76B | $2.89B | — | +4.7% |
| Total debt | $2.71B | $2.60B | $2.98B | $3.27B | — | +4.2% |
| Total liabilities | $9.11B | $8.48B | $7.74B | $7.32B | — | +7.4% |
| Retained earnings | — | — | — | — | $0 | — |
| Shareholder equity | $3.44B | $3.08B | $2.79B | $2.57B | — | +12.0% |
| Working capital | $2.39B | $2.10B | $2.39B | $2.54B | — | +13.9% |
| Net tangible assets | $723.40M | $572.70M | $455.50M | $321.00M | — | +26.3% |
| Shares issued | 740.47M | 740.47M | 740.47M | 740.47M | — | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $359.00M | $354.60M | $164.30M | -$203.50M | — | +1.2% |
| Depreciation & amortisation | $259.50M | $243.60M | $241.70M | $210.30M | — | +6.5% |
| Stock-based compensation | — | — | — | $2.90M | $0 | — |
| Change in working capital | $398.50M | $94.60M | $439.50M | $591.80M | — | +321.2% |
| Operating cash flow | $870.00M | $871.20M | $617.00M | $751.30M | — | -0.1% |
| Capital expenditure | -$483.90M | -$466.20M | -$430.80M | -$256.00M | — | -3.8% |
| Investing cash flow | -$611.70M | -$599.70M | -$447.60M | -$109.50M | — | -2.0% |
| Share buybacks | -$186.80M | $0 | $0 | $0 | — | — |
| Dividends paid | -$23.60M | $0 | -$13.40M | $0 | — | — |
| Financing cash flow | $146.10M | -$335.70M | -$348.70M | -$669.20M | — | +143.5% |
| Free cash flow | $386.10M | $405.00M | $186.20M | $495.30M | — | -4.7% |
| End cash position | $1.95B | $1.56B | $1.63B | $1.82B | — | +24.7% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.45B | $2.65B | $1.82B | $1.10B | $2.31B | -45.4% |
| Operating revenue | $1.45B | $2.65B | $1.82B | $1.10B | $2.31B | -45.4% |
| Cost of revenue | $1.19B | $2.21B | $1.47B | $913.90M | $1.88B | -46.3% |
| Gross profit | $260.20M | $442.20M | $352.80M | $189.10M | $429.60M | -41.2% |
| Research & development | $15.50M | $31.10M | $12.10M | $14.20M | $18.00M | -50.2% |
| Selling, general & admin | $133.80M | $152.80M | $141.60M | $120.20M | $132.70M | -12.4% |
| Total operating expense | $178.70M | $229.80M | $162.80M | $135.40M | $172.70M | -22.2% |
| Operating income | $81.50M | $212.40M | $190.00M | $53.70M | $256.90M | -61.6% |
| Net interest income | -$36.70M | $67.20M | -$113.50M | -$65.60M | -$35.50M | -154.6% |
| Pre-tax income | $41.30M | $137.70M | $47.10M | -$24.10M | $168.60M | -70.0% |
| Tax provision | $4.20M | $56.60M | -$22.10M | -$103.90M | $130.60M | -92.6% |
| Net income | $33.40M | $83.30M | $78.50M | $73.40M | $45.60M | -59.9% |
| Net income to common | $33.40M | $83.30M | $78.50M | $73.40M | $45.60M | -59.9% |
| Basic EPS | 0.19 | 0.45 | 0.44 | 0.40 | 0.25 | -59.2% |
| Diluted EPS | 0.19 | 0.45 | 0.44 | 0.40 | 0.25 | -59.2% |
| EBIT | $127.80M | -$59.90M | $190.00M | $137.80M | $216.40M | +313.4% |
| EBITDA | $181.00M | $17.90M | $249.60M | $188.40M | $290.40M | +911.2% |
| Basic shares | 179.93M | 183.16M | 178.41M | 183.63M | 183.65M | -1.8% |
| Diluted shares | 179.93M | 183.16M | 178.41M | 183.63M | 183.65M | -1.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.32B | $1.95B | — | $654.00M | $813.00M | $1.56B | -32.5% |
| Cash & short-term investments | $2.11B | $2.63B | — | $1.26B | $1.36B | $2.20B | -19.5% |
| Accounts receivable | $325.80M | $289.40M | — | $356.90M | $252.30M | $320.80M | +12.6% |
| Inventory | $3.67B | $3.18B | — | $3.55B | $3.49B | $2.90B | +15.1% |
| Total current assets | $7.18B | $7.15B | — | $6.52B | $6.26B | $6.51B | +0.5% |
| Property, plant & equipment | $2.26B | $2.24B | — | $2.18B | $2.10B | $2.05B | +0.9% |
| Goodwill & intangibles | $2.79B | $2.72B | — | $2.61B | $2.55B | $2.50B | +2.5% |
| Total assets | $12.96B | $12.92B | — | $12.07B | $11.70B | $11.82B | +0.3% |
| Total current liabilities | $4.85B | $4.76B | — | $4.91B | $4.74B | $4.42B | +1.9% |
| Current debt | $95.50M | $105.30M | — | $121.80M | $91.50M | $113.80M | -9.3% |
| Long-term debt | $2.59B | $2.49B | — | $2.08B | $1.95B | $2.38B | +4.3% |
| Total debt | $2.81B | $2.71B | — | $2.32B | $2.17B | $2.60B | +3.5% |
| Total liabilities | $9.29B | $9.11B | — | $8.47B | $8.23B | $8.48B | +2.0% |
| Retained earnings | $33.40M | — | — | $125.70M | $73.40M | — | — |
| Shareholder equity | $3.29B | $3.44B | — | $3.33B | $3.19B | $3.08B | -4.4% |
| Working capital | $2.33B | $2.39B | — | $1.61B | $1.52B | $2.10B | -2.3% |
| Net tangible assets | $504.40M | $723.40M | — | $726.70M | $641.20M | $572.70M | -30.3% |
| Shares issued | 740.46M | 740.47M | 714.58M | 733.57M | 740.47M | — | -0.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $37.10M | $81.10M | $69.20M | $79.80M | $38.00M | -54.3% |
| Depreciation & amortisation | $53.20M | $77.80M | $59.60M | $50.60M | $74.00M | -31.6% |
| Change in working capital | -$418.30M | $726.00M | -$201.60M | -$156.40M | $884.50M | -157.6% |
| Operating cash flow | -$388.40M | $857.00M | -$76.10M | -$183.80M | $1.05B | -145.3% |
| Capital expenditure | -$156.00M | -$90.20M | -$113.20M | -$137.90M | -$105.00M | -72.9% |
| Investing cash flow | -$155.40M | -$141.90M | -$187.40M | -$134.10M | -$138.50M | -9.5% |
| Share buybacks | -$183.70M | -$172.30M | $0 | -$14.50M | — | -6.6% |
| Dividends paid | -$12.70M | -$14.50M | -$9.10M | $0 | — | +12.4% |
| Financing cash flow | -$97.70M | $186.30M | $105.60M | -$432.40M | -$178.10M | -152.4% |
| Free cash flow | -$544.40M | $766.80M | -$189.30M | -$321.70M | $942.20M | -171.0% |
| End cash position | $1.32B | $1.95B | $654.00M | $813.00M | $1.56B | -32.5% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
65.22
+0.28% from price
SMA 20
62.74
+4.24% from price
SMA 50
58.38
+12.03% from price
SMA 100
55.32
+18.23% from price
SMA 200
56.10
+16.58% from price
EMA 12
64.51
+1.37% from price
EMA 26
62.10
+5.32% from price
EMA 50
59.39
+10.12% from price
RSI (14)
62.3
Neutral
MACD (12,26,9)
2.42
Hist 0.09
ATR (14)
1.61
2.47% of price
Realised vol 30D
34.4%
Annualised
Bollinger upper
68.61
20, 2σ
Bollinger lower
56.87
20, 2σ
50 / 200 cross
Golden
58.38 vs 56.10
Trend bias
Above 200
+16.58%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.17
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
34.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-29.4%
Peak to trough
Max drawdown 5Y
-50.6%
Peak to trough
ATR 14
1.61
2.47% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jun 8, 26 | Scotiabank | INITIATED | — | Sector Outperform |
| May 12, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Mar 10, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Nov 7, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Oct 15, 25 | Citigroup | MAINTAINED | Buy | Buy |
| Sep 11, 25 | B of A Securities | MAINTAINED | Buy | Buy |
| Aug 15, 25 | UBS | MAINTAINED | Sell | Sell |
| Aug 7, 25 | Goldman Sachs | MAINTAINED | Buy | Buy |
| Jul 31, 25 | Wolfe Research | UPGRADE | Peer Perform | Outperform |
| Jun 4, 25 | HSBC | UPGRADE | Hold | Buy |
| May 12, 25 | Goldman Sachs | MAINTAINED | Buy | Buy |
Headlines
Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?
Insider Monkey · 7m ago
Dow Jones Futures Fall With Tariffs In Focus; Nvidia, Warsh Ahead
Investor's Business Daily · 10m ago
Syria says Israel talks addressed de-escalation, staying out of Israel-Turkey tensions
AFP · 14m ago
FIA Hails Success of Landmark INDYCAR Freedom 250 Grand Prix as Motorsport Takes Centre Stage in Washington D.C.
Business Wire · 18m ago
The next big oil trade may have nothing to do with oil stocks
TheStreet · 18m ago
First lady Melania Trump says she 'loved' racing as a child
USA TODAY · 18m ago
Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?
Insider Monkey · 19m ago
Crowder College offering training courses in August, September
The Joplin Globe, Mo. · 20m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.